Tumour Lysis Syndrome Flashcards
1
Q
TLS : definition
A
- oncologic emergency
- massive tumour cell lysis
- release of K, P04, nucleic acids –> uric acid into systemic circulation
- occurs with cytotoxic chemotherapy
- can also occur with steroids, radiation, cytolytic antibody therapy
- Cancers:
- high grade lymphoma (Burkitt’s)
- ALL
- any cancer with high proliferative rate, large tumour burden, sensitivity to cytotoxic chemo
2
Q
Pathogenesis
A
- massive quantities of intracellular contents in systemic circulation
- K, P04, nucleic acid (metabolized to uric acid)
- Hyperkalemia
- Hyperphosphatemia
- Hypocalcemia
- Hyperuricemia
- Acute kidney injury
3
Q
Clinical Manifestations
A
- Nausea
- Lethargy
- Vomiting
- Diarrhea
- Anorexia
- Hematuria
- Heart Failure
- Cardiac dysrthymias
- Seizures
- Muscle cramps
- Tetany
- Syncope
- Sudden Death
4
Q
Diagnosis of Tumour Lysis Syndrome
A
2 or more within 3 days before or 7 days after Cytotoxic chemotherapy
- Uric acid 25% increase
- Potassium > 6 or 25% incrase
- Phosphorus > 1.45 mmol/l or 25 % increase
- Calcium < 1.75 mmol/L 25% DECREASE
Clinical diagnosis also includes:
- Increased Creatinine
- Cardiac dysrhythmias
- Seizure
5
Q
Risk factors for TLS
A
- Hematologic malignancies
- high tumour cell proliferation
- large tumour burden
- bulky disease
- LDH > 2x ULN
- bone marrow involvement
- Hyperuricemia pre treatment
- Nephropathy
- Dehydration
- RARE for solid tumours
6
Q
Implicated cancer treatments
A
- Cytotoxic chemotherapies
- Docetaxal
- Tyrosine kinase inhibitors - pazopanib
- monoclonal antibodies - rituximab
7
Q
Prevention of TLS
A
- IV hydration
- Loop diuretics
- Hypouricemic drugs
- allopurinol
- rasburicase
- NaHC03 if metabolic acidosis
8
Q
Treatment TLS
A
- cardiac monitoring, regular labs q4h
- Rasburicase
- breaks down serum uric acid
- Treat electrolyte abnormalities
- Hyperkalemia
- Hypocalcemia
- Hyperphosphatemia
- Hydration +/- loop diuretic
- Renal Replacement Therapy
- oliguria/anuria
- intractable fluid overload
- persistent hyperK
- Symptomatic hypocalcemia